Infinity Stock Performance

INFI -  USA Stock  

USD 2.59  0.06  2.26%

On a scale of 0 to 100, Infinity Pharmaceuti holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 0.3234, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Infinity's beta means in this case. As returns on the market increase, Infinity Pharmaceuti returns are expected to increase less than the market. However, during the bear market, the loss on holding Infinity Pharmaceuti will be expected to be smaller as well. Although it is vital to follow Infinity Pharmaceuti current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-seven technical indicators for Infinity Pharmaceuti, which you can use to evaluate the performance of the firm. Please utilizes Infinity Pharmaceuti information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis to make a quick decision on whether Infinity Pharmaceuti current trending patterns will revert.

Infinity Stock Performance 

 Infinity Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Infinity Pharmaceuti are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Infinity Pharmaceuti reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Infinity Price Channel

Quick Ratio9.22
Fifty Two Week Low1.0400
Target High Price14.00
Fifty Two Week High5.9800
Target Low Price4.00

Infinity Pharmaceuti Relative Risk vs. Return Landscape

If you would invest  222.00  in Infinity Pharmaceuti on July 25, 2021 and sell it today you would earn a total of  37.00  from holding Infinity Pharmaceuti or generate 16.67% return on investment over 90 days. Infinity Pharmaceuti is currently generating 0.7387% in daily expected returns and assumes 10.8417% risk (volatility on return distribution) over the 90 days horizon. In different words, 92% of stocks are less volatile than Infinity, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Infinity Pharmaceuti is expected to generate 15.2 times more return on investment than the market. However, the company is 15.2 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The DOW is currently generating roughly 0.04 per unit of risk.

Infinity Pharmaceuti Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Infinity Pharmaceuti's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Infinity Pharmaceuti, and traders can use it to determine the average amount a Infinity Pharmaceuti's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0681

Good Returns
Average Returns
Small ReturnsINFI
Negative Returns
Estimated Market Risk
  actual daily
 92 %
of total potential
Expected Return
  actual daily
 14 %
of total potential
Risk-Adjusted Return
  actual daily
 5 %
of total potential
Based on monthly moving average Infinity Pharmaceuti is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Infinity Pharmaceuti by adding it to a well-diversified portfolio.

About Infinity Pharmaceuti Performance

To evaluate Infinity Pharmaceuti Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Infinity Pharmaceuti generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Infinity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Infinity Pharmaceuti stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Infinity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Return on Investment(174.51) (179.10) 
Return on Average Assets(0.84) (0.86) 
Return on Average Equity 3.19  3.44 
Return on Invested Capital(2.86) (2.94) 
Return on Sales(22.13) (22.72) 
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Things to note about Infinity Pharmaceuti

Checking the ongoing alerts about Infinity Pharmaceuti for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infinity Pharmaceuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Infinity Pharmaceuti Alerts

Equity Alerts and Improvement Suggestions

Infinity Pharmaceuti is way too risky over 90 days horizon
Infinity Pharmaceuti appears to be risky and price may revert if volatility continues
Infinity Pharmaceuti was previously known as Infinity Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.91 M. Net Loss for the year was (43.03 M) with loss before overhead, payroll, taxes, and interest of (26.08 M).
Infinity Pharmaceuti currently holds about 97.26 M in cash with (39.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Roughly 57.0% of the company shares are owned by institutional investors
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.